Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Bonanni

Showing results (151-160 of 265) with videos related to

Pageof 27
Sort By:
Tumori|April 13, 2012
Lifestyle and breast cancer recurrences: the DIANA-5 trialAnna Villarini, Patrizia Pasanisi, Adele Traina, et al.
Breast Cancer Research : BCR|November 10, 2016
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trialHarriet Johansson, Kathryn P Gray, Olivia Pagani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2021
Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive DiseaseAndrea DeCensi, Matteo Puntoni, Harriet Johansson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2019
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial NeoplasiaAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
Nutrients|September 28, 2021
Adherence to Dietary Recommendations after One Year of Intervention in Breast Cancer Women: The DIANA-5 TrialEleonora Bruno, Vittorio Krogh, Giuliana Gargano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 TrialHarriet Johansson, Debora Macis, Martino Oliva, et al.
Endocrine Connections|July 24, 2019
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer riskPiera Rizzolo, Valentina Silvestri, Virginia Valentini, et al.
Contemporary Clinical Trials|July 3, 2021
Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trialAliana Guerrieri-Gonzaga, Davide Serrano, Parjhitham Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled AnalysisSara Gandini, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 22, 2014
PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of BergamoIrene Catucci, Paolo Peterlongo, Sara Ciceri, et al.
Pageof 27

Showing results (151-160 of 265) with videos related to

Sort By:
Pageof 27
Tumori|April 13, 2012
Lifestyle and breast cancer recurrences: the DIANA-5 trialAnna Villarini, Patrizia Pasanisi, Adele Traina, et al.
Breast Cancer Research : BCR|November 10, 2016
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trialHarriet Johansson, Kathryn P Gray, Olivia Pagani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2021
Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive DiseaseAndrea DeCensi, Matteo Puntoni, Harriet Johansson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2019
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial NeoplasiaAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
Nutrients|September 28, 2021
Adherence to Dietary Recommendations after One Year of Intervention in Breast Cancer Women: The DIANA-5 TrialEleonora Bruno, Vittorio Krogh, Giuliana Gargano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 TrialHarriet Johansson, Debora Macis, Martino Oliva, et al.
Endocrine Connections|July 24, 2019
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer riskPiera Rizzolo, Valentina Silvestri, Virginia Valentini, et al.
Contemporary Clinical Trials|July 3, 2021
Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trialAliana Guerrieri-Gonzaga, Davide Serrano, Parjhitham Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled AnalysisSara Gandini, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 22, 2014
PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of BergamoIrene Catucci, Paolo Peterlongo, Sara Ciceri, et al.
Pageof 27